Globus Medical, Inc. (NYSE: GMED - Get Free Report) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totaling 2,831,226 shares, a decline of
AUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 3
Robotics stocks like GMED, ADSK, MCHP and ROK gain momentum as physical AI, automation and medical robotics drive a major industry growth wave in 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GMED rides on NuVasive synergies, strong cash flow and rapid innovation, but macro pressures and rising costs cloud its near-term outlook.
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

New Strong Buy Stocks for April 8th

06:51am, Wednesday, 08'th Apr 2026
BE, SM, KRUS, GMED and BP have been added to the Zacks Rank #1 (Strong Buy) List on April 8th, 2026.
Flowserve, California Resources and Globus Medical stand out as sales-growth buys as oil spikes and Iran-Strait tensions shake markets.
Allspring Global Investments Holdings LLC trimmed its stake in shares of Globus Medical, Inc. (NYSE: GMED) by 6.2% in the fourth quarter, according to the company in its most recent filing with the Se
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Globus Medical Announces Board Departure

05:25pm, Monday, 23'rd Mar 2026
AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical I
GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.
Bridgefront Capital LLC acquired a new stake in Globus Medical, Inc. (NYSE: GMED) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor
ArrowMark Colorado Holdings LLC increased its holdings in Globus Medical, Inc. (NYSE: GMED) by 25.1% during the third quarter, according to the company in its most recent 13F filing with the Securitie
ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE